A Phase 1 Dose Evaluation Study of the Safety and Preliminary Efficacy of Anti-CD19 Allogeneic CRISPR-Cas9-Engineered T Cells (CTX112) in Adult Subjects With Refractory Autoimmune Disease
NCT06925542 · RECRUITING · Phase 1
ReadTheTrial indexes 1 studies for Sle Systemic Lupus. The most common development stage is Phase 1 (1 trials). Each trial page translates ClinicalTrials.gov eligibility, outcomes, and design into patient-friendly language so you can compare options quickly.
1 clinical trials found for Sle Systemic Lupus.
| Phase | Trials | Distribution |
|---|---|---|
| Phase 1 | 1 | 100% |
There are 1 clinical trials listed for Sle Systemic Lupus. These span various phases from early safety studies to post-approval monitoring. Browse the trial listings below for details.
Look for trials with "Recruiting" status in the listings below, or visit our recruiting page to filter by condition. Each trial page includes decoded eligibility criteria to help you determine if you qualify.
Current Sle Systemic Lupus trials are distributed across: Phase 1 (1).